MEDITE Cancer Diagnostics — Post-IPO Equity
MEDITE Cancer Diagnostics raised $5.4M in a Post-IPO Equity round. View investors, financials, and press on Fsome.
Round Details
- Funded Company
- MEDITE Cancer Diagnostics
- Round Type
- Post-IPO Equity
- Amount Raised
- $5.4M
- Announced
- October 3, 2017
Canonical: https://fsome.com/funding/medite-cancer-diagnostics-post-ipo-equity-6650182 · For the full investor list, press references, and related rounds, please enable JavaScript.